HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anti-aging peptide from DSM

This article was originally published in The Rose Sheet

Executive Summary

New peptide formula Syn-Glycan from Swiss supplier DSM Nutritional Products can be used as a bioactive ingredient in cosmetics to reduce visible signs of aging, boosting skin's production of hyaluronan in the dermis which "firms skin from the inside out." Product also increases levels of proteins decorin and lumican, which make collagen fibers thinner and stronger. Part of the appeal of Syn-Glycan is its versatility, says Dr. Goede Schueler, senior business development manager for skin care. The glycerin-based aqueous solution can be used in firming treatments, facial contour and remodeling creams, anti-sagging treatments, moisturizing lotions, anti-aging solutions and anti-cellulite gels, firm says. The 2007 acquisition of cosmetic ingredient specialist Pentapharm made personal care a "key area" of development for DSM (1"The Rose Sheet" July 9, 2007)

You may also be interested in...



DSM acquires Pentapharm

DSM Nutritional Products' acquisition of cosmetic active ingredient specialist Pentapharm further strengthens its No. 1 position as the global leading supplier of active ingredients for skin care and sun care, firm announces July 7. Headquartered in Basel, Switzerland, Pentapharm offers patent-protected cosmetic active ingredients such as Erythrulose for self-tanning, the anti-wrinkle synthetic tripeptide Syn-Ake, and Vialox, "a highly effective topical alternative to Botox," in addition to ingredients for body-slimming and whitening products. The acquisition "enriches our existing personal care portfolio of vitamins and sun-filters with highly specialized actives," DSM's Krijn Rietveld, senior VP and head of new business development, says. Personal care is a "key area" DSM plans to build upon by 2010, board member Stephan Tanda adds. Pentapharm, which commands annual revenues of approximately $54.5 mil., employs about 200 people at locations in Switzerland, Japan and Brazil. The parties have agreed not to disclose financial details...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016508

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel